| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P2093 | author name string | Zhe Yang | |
| Lin Zhou | |||
| Shusen Zheng | |||
| Jia Yao | |||
| Sheng Gao | |||
| Zhiyun Zheng | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS | Q24684141 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Systematic review of actual 10-year survival following resection for hepatocellular carcinoma | Q26998612 | ||
| Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Innate immune recognition | Q27860721 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
| Proinflammatory cytokines in CRP baseline regulation | Q28645842 | ||
| Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression | Q29615766 | ||
| C-reactive protein and the risk of incident colorectal cancer | Q34294791 | ||
| Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients | Q35978475 | ||
| The liver as the site of C-reactive protein formation | Q36267987 | ||
| Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas | Q37364263 | ||
| Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma | Q38052472 | ||
| Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression | Q39788628 | ||
| Preoperative elevation of serum C--reactive protein is predictive for prognosis in myeloma bone disease after surgery | Q42277957 | ||
| Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma | Q43837250 | ||
| Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer | Q44076023 | ||
| Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy | Q44357744 | ||
| Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy | Q46132260 | ||
| Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria | Q46138944 | ||
| Persistent elevated C-reactive protein after treatment is an independent marker of a poor prognosis in patients with hepatocellular carcinoma | Q46679276 | ||
| Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. | Q51731357 | ||
| Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma. | Q53265835 | ||
| Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers | Q56985475 | ||
| C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality | Q59649682 | ||
| Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer | Q61853683 | ||
| C-Reactive protein predicts short-term mortality in patients with cirrhosis | Q63284638 | ||
| Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma | Q80626462 | ||
| Serum C-reactive protein levels predict survival in hepatocellular carcinoma | Q81226961 | ||
| Liver transplantation for hepatocellular carcinoma: Hangzhou experiences | Q81525414 | ||
| The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma | Q81547801 | ||
| Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma | Q83220378 | ||
| Impact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patients | Q83689353 | ||
| Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma | Q83770414 | ||
| Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma | Q84597535 | ||
| C-reactive protein, a prognostic marker in hepatocellular carcinoma | Q85893949 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| systematic review | Q1504425 | ||
| meta-analysis | Q815382 | ||
| P304 | page(s) | 653-664 | |
| P577 | publication date | 2013-04-01 | |
| P1433 | published in | International Journal of Medical Sciences | Q10927439 |
| P1476 | title | Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis | |
| P478 | volume | 10 |
| Q91677799 | A first case of hepatocellular carcinoma in the baboon (Papio spp.) placenta |
| Q30977795 | A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study |
| Q42360902 | C-reactive protein and bacterial infection in cirrhosis |
| Q33275999 | C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum--a single center pilot study |
| Q41742939 | Cigarette smoking increases the risk of mortality from liver cancer: A clinical-based cohort and meta-analysis |
| Q37588336 | Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice |
| Q47144193 | Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial. |
| Q36511833 | Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population |
| Q99728727 | Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies |
| Q33718321 | Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation |
| Q31140554 | Integrated Multiple "-omics" Data Reveal Subtypes of Hepatocellular Carcinoma |
| Q36962089 | Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome |
| Q28074653 | Liver transplantation for advanced hepatocellular carcinoma |
| Q38821374 | Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun |
| Q28551503 | Long Term Influence of Carbon Nanoparticles on Health and Liver Status in Rats |
| Q41544562 | Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment |
| Q41813489 | Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas |
| Q59793687 | Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue |
| Q64927064 | Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study. |
| Q40235716 | Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma |
| Q37382576 | Predictive values of serum VEGF and CRP levels combined with contrast enhanced MRI in hepatocellular carcinoma patients after TACE. |
| Q35690319 | Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis. |
| Q26776504 | Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis |
| Q92669100 | Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer |
| Q45975274 | Prognostic role of C-reactive protein in patients with nasopharyngeal carcinoma: A meta-analysis and literature review. |
| Q28083684 | Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis |
| Q35161694 | Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis |
| Q57116768 | Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis |
| Q47629558 | Prognostic value of the combination of serum levels of vascular endothelial growth factor, C-reactive protein and contrast-enhanced ultrasound in patients with primary liver cancer who underwent transcatheter arterial chemoembolization |
| Q90214924 | Quality of life in patients undergoing repetitive TACE for the treatment of intermediate stage HCC |
| Q49686127 | Radical versus conservative surgical treatment of liver hydatid cysts: a meta-analysis |
| Q37266401 | Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B |
| Q89701689 | Role of inflammatory markers as hepatocellular cancer selection tool in the setting of liver transplantation |
| Q51715946 | Serum C-reactive protein and S100A12 concentrations in dogs with hepatic disease. |
| Q61443474 | Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation |
| Q35850891 | Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1. |
| Q26786170 | The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis |
| Q47273007 | The impact of elevated C-reactive protein level on the prognosis for oro-hypopharynx cancer patients treated with radiotherapy. |
Search more.